In Manitoba's public drug plan, dispensing costs for one million tablets of generic medicines reduced to 10% (previously 18%) of their brand-name reference price were 287 thousand Canadian dollars in FY 2016/17 and 323 thousand Canadian dollars in FY 2021/22. This statistic depicts the dispensing costs for tablets of common generic drugs by public drug plan in Canada comparing FY 2016/17 and FY 2021/22, in thousand Canadian dollars.
Dispensing costs for tablets of common generic drugs by public drug plan in Canada comparing 2016/2017 and 2021/2022
(in 1,000 Canadian dollars)
Subject to the pCPA–CGPA agreement that reduced the prices of these medicines to 10% of their brand-name reference price:
atorvastatin, ramipril, venlafaxine, amlodipine, omeprazole, rabeprazole, rosuvastatin, pantoprazole, citalopram, simvastatin, clopidogrel,
gabapentin, metformin, olanzapine, olanzapine ODT, donepezil, ezetimibe, quetiapine, ranitidine, and zopiclone.
Long-term care homes were excluded from this analysis, as they may not have a typical dispensing frequency due to the more
specialized needs of their patients. The following sub-plans were not included in the analysis: BC: Permanent Residents of Licensed
Residential Care Facilities; MB: Personal Home Care/Nursing Homes; NB: Individuals in Licensed Residential Facilities, Nursing
Home Residents; ON: Long Term Care, Home Care and Homes for Special Care. Yukon is not reported due to data limitations.
* Total results for the drug plans captured in this figure.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PMPRB. (December 12, 2023). Dispensing costs for tablets of common generic drugs by public drug plan in Canada comparing 2016/2017 and 2021/2022 (in 1,000 Canadian dollars) [Graph]. In Statista. Retrieved October 31, 2024, from https://www.statista.com/statistics/712629/dispensing-costs-for-tablets-of-generic-drugs-in-canada-by-public-drug-plans/
PMPRB. "Dispensing costs for tablets of common generic drugs by public drug plan in Canada comparing 2016/2017 and 2021/2022 (in 1,000 Canadian dollars)." Chart. December 12, 2023. Statista. Accessed October 31, 2024. https://www.statista.com/statistics/712629/dispensing-costs-for-tablets-of-generic-drugs-in-canada-by-public-drug-plans/
PMPRB. (2023). Dispensing costs for tablets of common generic drugs by public drug plan in Canada comparing 2016/2017 and 2021/2022 (in 1,000 Canadian dollars). Statista. Statista Inc.. Accessed: October 31, 2024. https://www.statista.com/statistics/712629/dispensing-costs-for-tablets-of-generic-drugs-in-canada-by-public-drug-plans/
PMPRB. "Dispensing Costs for Tablets of Common Generic Drugs by Public Drug Plan in Canada Comparing 2016/2017 and 2021/2022 (in 1,000 Canadian Dollars)." Statista, Statista Inc., 12 Dec 2023, https://www.statista.com/statistics/712629/dispensing-costs-for-tablets-of-generic-drugs-in-canada-by-public-drug-plans/
PMPRB, Dispensing costs for tablets of common generic drugs by public drug plan in Canada comparing 2016/2017 and 2021/2022 (in 1,000 Canadian dollars) Statista, https://www.statista.com/statistics/712629/dispensing-costs-for-tablets-of-generic-drugs-in-canada-by-public-drug-plans/ (last visited October 31, 2024)
Dispensing costs for tablets of common generic drugs by public drug plan in Canada comparing 2016/2017 and 2021/2022 (in 1,000 Canadian dollars) [Graph], PMPRB, December 12, 2023. [Online]. Available: https://www.statista.com/statistics/712629/dispensing-costs-for-tablets-of-generic-drugs-in-canada-by-public-drug-plans/
